Colistin, rifampicin, and meropenem administered as single agents in a model of pneumonia caused by a carbapenem-resistant Acinetobacter baumannii

被引：4
|
作者：
Cassisa, Viviane [1 ,2 ]
Joly-Guillou, Marie-Laure [1 ,2 ]
Pailhories, Helene [1 ,2 ]
Coron, Noemie [2 ]
Eveillard, Matthieu [1 ,2 ]
机构：
[1] Grp Etude Interact Hotes Pathogenes, GEIHP, UPRES EA 3142, Corsica, France
[2] CHU Angers, Lab Bacteriol Hyg, F-49000 Angers, France
来源：
JOURNAL OF INFECTION | 2014年 / 69卷 / 05期
关键词：
EFFICACY; IMIPENEM;
D O I：
10.1016/j.jinf.2014.07.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：516 / +
页数：2
相关论文
共 50 条
  • [21] Metabolomics Method in Understanding and Sensitizing Carbapenem-Resistant Acinetobacter baumannii to Meropenem
    Li, Xia
    Feng, Dingyun
    Zhou, Jianxia
    Wu, Wenbin
    Zheng, Wenzheng
    Gan, Wenlei
    Jiang, Ming
    Li, Hui
    Peng, Xuanxian
    Zhang, Tiantuo
    ACS INFECTIOUS DISEASES, 2023, 10 (01): : 184 - 195
  • [22] Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study
    Jeon, Cheon-Hoo
    Kim, Si -Ho
    Kim, Hyoung - Tae
    Park, Kyoung-Jin
    Wi, Yu Mi
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (05) : 774 - 779
  • [23] Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
    Park, Sang-Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (39)
  • [24] The susceptibility to colistin and tigecycline of carbapenem-resistant Acinetobacter baumannii isolates in Turkey
    Cakirlar, F. Koksal
    Gonullu, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 85 - 85
  • [25] Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
    Saballs, Mireia
    Pujol, Miquel
    Tubau, Fe
    Pena, Carmen
    Montero, Abelardo
    Dominguez, M. Angeles
    Gudiol, Francesc
    Ariza, Javier
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) : 697 - 700
  • [26] Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia
    Khalili, Hossein
    Shojaei, Lida
    Mohammadi, Mostafa
    Beigmohammadi, Mohammad-Taghi
    Abdollahi, Alireza
    Doomanlou, Mahsa
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (09) : 901 - 911
  • [27] Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia
    Jeong, Yun-Jeong
    Gu, Namyi
    Kwack, Won Gun
    Kang, Yunseong
    Park, Seong Yeon
    Yoon, Young-Soon
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 315 - 323
  • [28] Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii
    Moon, Chisook
    Kwak, Yee Gyung
    Kim, Baek-Nam
    Kim, Eu Suk
    Lee, Chang-Seop
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (05) : 916 - 919
  • [29] EFFECTIVENESS OF COLISTIN WITH RIFAMPICIN AND MEROPENEM AGAINST COLISTIN-RESISTANT ACINETOBACTER BAUMANNII STRAINS: AN IN VITRO STUDY
    Mosca, Adriana
    Dalfino, Lidia
    Romanelli, Federica
    Stolfa, Stefania
    Del Prete, Raffaele
    Santacroce, Luigi
    PHARMACOPHORE, 2020, 11 (02): : 1 - 6
  • [30] Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
    Kim, Yong Kyun
    Lee, Jae Ha
    Lee, Hyun-Kyung
    Chung, Byung Cheol
    Yu, Seung Jung
    Lee, Ho-Young
    Park, Jin-Han
    Kim, Sunyoung
    Kim, Hyeon-Kuk
    Kiem, Sungmin
    Jang, Hang-Jea
    JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 555 - 567
12345